Page 22 - Nasdaq

10 reasons Goldman Sachs believes the bull-run in markets will continue

Major global indices have all gained 37 per cent to 75 per cent since their respective March 2020 low

Nasdaq Whale: Softbank's huge tech options bet answers stock rally riddle

Investors have gone back and forth on whether Son, 63, is a true visionary or more of a gambler

SoftBank unmasked as 'Nasdaq whale' that stoked tech rally: Report

Softbank has been snapping up options in tech stocks over the past month in huge amounts, contributing to the largest trading volumes in contracts linked to individual firms in nearly 10 years

Salesforce to replace Exxon Mobil Corp in major Dow Jones shake-up

Prompted by Apple's stock split, Exxon will exit the index after 92 years

Bears are going extinct in US stock market's $13 trillion rebound

Virtually every constituency in the market has gotten more bullish as the S&P 500 surged 52% in five months

S&P 500 inches closer to record high as coronavirus stimulus bets climb

Ultra-low interest rates, trillions of dollars in stimulus and, more recently, a better-than-feared second-quarter earnings season have allowed all three of Wall Street's main indexes to recover

Trump admin proposes delisting of Chinese firms failing to meet audit norms

The latest move of Trump Administration is part of its effort to crackdown on Chinese companies

Nasdaq-beating market rally sends BSE IT Index to a record high

The 50-member S&P BSE Information Technology (BSE IT) Index jumped to a record high this week, taking its advance since the end of March to more than 40%

Market Ahead, July 30: All you need to know before the opening bell

The quarterly results announcement by Reliance Industries and HDFC will be the major market mover today. Analysts expect a dent in RIL's retail and energy verticals in the June quarter

Mohun Bagan features on NASDAQ billboards, goes global on its special day

Iconic Indian football club Mohun Bagan went global on Wednesday as it became the country's first ever sports entity to feature on NASDAQ billboards in New York's Times Square

Market Ahead, July 29: Top factors that could guide markets today

The expiry of derivative contracts of the July series tomorrow may keep today's session volatile

Market Ahead, July 28: All you need to know before the opening bell

A total of 132 companies, including UltraTech Cement, Nestle India, and IDBI Bank, are scheduled to announce their results today

Wall Street slides as Intel leads sell-off, earnings and pandemic weigh

For the second day in a row, the tech sector weighed heaviest on all three major US stock averages

Market Ahead, July 24: All you need to know before the opening bell

Today, a total of 71 companies including ITC, Asian Paints, and Ambuja Cements are scheduled to announce their quarterly results

Wall Street opens higher on upbeat corporate earnings, stimulus hopes

The Dow Jones Industrial Average rose 152.27 points, or 0.57%, at the open to 26,833.14, and the S&P 500 opened higher by 16.68 points, or 0.51%, at 3,268.52.

Wall Street jumps on Goldman's strong numbers, Covid-19 vaccine hopes

The Dow Jones Industrial Average rose 367.22 points, or 1.38 per cent

US stocks gain as investors weigh Covid-19 impact on economic recovery

The S&P US Listed China 50 index, which is designed to track the performance of the 50 largest Chinese companies listed on US exchanges by total market cap, logged a weekly rise of 6 per cent

Market Ahead, July 10: All you need to know before the opening bell

The June quarter results of TCS will be a major focus for the Indian markets today which is also likely to decide how the rest of the IT space trades throughout the session

Market Ahead, July 9: Top factors that could guide markets today

A major focus today will be on TCS which is scheduled to kick-off the April-June 2020 earnings season for IT companies today

Biogen seeks US approval for potential Alzheimer's drug, stock jumps

The number of people in the United States living with Alzheimer's, the most common form of dementia, is expected to triple to nearly 14 million by 2050 without effective treatments